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Telemonitoring or structured telephone support
programmes for patients with chronic heart failure:
systematic review and meta-analysis
Robyn A Clark, scholar,1 Sally C Inglis, scholar,2 Finlay A McAlister, associate professor ,3
John G F Cleland, professor,4 Simon Stewart, professor 5
ABSTRACT
Objective To determine whether remote monitoring
(structured telephone support or telemonitoring) without
regular clinic or home visits improves outcomes for
patients with chronic heart failure.
Data sources 15 electronic databases, hand searches of
previous studies, and contact with authors and experts.
Data extraction Two investigators independently
screened the results.
Review methods Published randomised controlled trials
comparing remote monitoring programmes with usual
care in patients with chronic heart failure managed within
the community.
Results 14 randomised controlled trials (4264 patients)
of remote monitoring met the inclusion criteria: four
evaluated telemonitoring, nine evaluated structured
telephone support, and one evaluated both. Remote
monitoring programmes reduced the rates of admission
to hospital for chronic heart failure by 21% (95%
confidence interval 11% to 31%) and all cause mortality
by 20% (8% to 31%); of the six trials evaluating health
related quality of life three reported significant benefits
with remotemonitoring, andof the four studies examining
healthcare costs with structured telephone support three
reported reduced cost and one no effect.
Conclusion Programmes for chronic heart failure that
include remote monitoring have a positive effect on
clinical outcomes in community dwelling patients with
chronic heart failure.
INTRODUCTION
Chronic heart failure is a common diagnosis, carries a
poor prognosis, and affected patients are major consu-
mers of healthcare resources.1 As the prevalence of
chronic heart failure is increasing this situation will
deteriorate unless new management strategies are
developed.2 The effectiveness of multidisciplinary
non-pharmacological approaches for improving out-
comes in patients with chronic heart failure has been
well established in over 30 randomised trials.3-7 As
most of these trials have tested multifaceted
approaches, however, it has been difficult to identify
the incremental benefits of the components of each
intervention.6 Nevertheless, it is clear that within
most populations access to these programmes is lim-
ited as a result of barriers related to funding or
geography.8 As a result interest is increasing in remote
monitoringmodels for delivering care, which incorpo-
rate information communication technology either as
telemonitoring (transfer of physiological data such as
blood pressure, weight, electrocardiographic details,
and oxygen saturation through telephone or digital
cable from home to healthcare provider) or as regular
structured telephone contacts between patients and
healthcare providers, which may or may not include
the transfer of physiological data.6
Earlier reviews of multidisciplinary programmes for
chronic heart failure have been unable to make defini-
tive conclusions about the value of remote monitoring
strategies given the paucity of relevant studies and
patient numbers at the time of these analyses.5 6 How-
ever, several studies with relatively large numbers of
patients have since been published, permitting a
more detailed analysis. We evaluated the effect of
remote monitoring strategies in patients with chronic
heart failure andwhether the effect differed by the type
of technology used for the communication of
information.
METHODS
We updated two earlier systematic reviews that dealt
with telemonitoring56 by searching 15 electronic data-
bases using search methods recommended by the
CochraneHeart ReviewGroup.9 All randomised trials
evaluating remote monitoring programmes published
between 1 January 2002 and 6 May 2006 were
included. Databases searched included the Cochrane
library and the Cochrane CENTRAL register of con-
trolled trials, Medline (1 January 2002 to 6May 2006),
Embase, CINAHL (1 January 2002 to 6 May 2006),
AMED, ISI web of knowledge, HSTAT, Ingenta, Zec-
toc, LILACS, and science citation index expanded (to
search forward to detect studies citing the original
reviews), DARE, national research register, Psych
Info, and web of science. We also hand searched the
reference lists in 21 published systematic reviews of
disease management programmes in chronic heart
failure,3-7 10-26 149 review articles on telephone support
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programmes in chronic disease, and those studies iden-
tified in our electronic searches that met the inclusion
criteria. Unpublished conference proceedings were
reviewed and published abstracts were included if the
authors replied to our request and sufficient details and
outcomes of studies were retrieved. Finally, we com-
municated with the principal investigators of the iden-
tified trials and with national and international experts
in the specialty to identify any studies we had poten-
tially missed. We did not restrict study inclusion by
language but did limit our review to only randomised
controlled trials.
We applied the highly sensitive search strategy from
the Cochrane Collaboration.9 Keywords for searches
of the database included heart failure (exp), cardiac
failure (exp), telemedicine (exp), telecare (exp), tele-
monitoring (exp), teleconsultation (exp), teleconfer-
ence (exp), telecommunications (exp), case
management (exp), comprehensive health care (exp),
disease management (exp), health services research
(exp), home care services (exp), clinical protocols
(exp), patient care planning (exp), nurse led clinics
and special clinics (exp), randomised controlled trial
(s), controlled clinical trial, random allocation, double
blind method, single blind method, clinical trial(s),
research design, comparative study, follow-up study,
and prospective study.
Search strategies were written for each database and
double checked by the second reviewer, under the
direction and supervision of a medical librarian.
Types of interventions
Remote monitoring programmes started by a health
professional (medical, nursing, social work, pharma-
cists) for patients with chronic heart failure living at
home were eligible for inclusion if the monitoring
was carried out at least once in the first month after
hospital discharge, was targeted towards the patient
(that is, the patient had to be the person on the tele-
phone), was structured (as opposed to offering
telephone follow-up on an “as needed” basis), and
was to be delivered as the only aftercare intervention
without home visits or more than usual clinic follow-
up.We excluded studies in which the remote monitor-
ingwas intendedprimarily to dealwith the problemsof
care givers rather thanof patients.Weapriori classified
programmes as being structured telephone support if
they consisted of standardised telephone contact of
patients with chronic heart failure and relied on report-
ing of symptoms alone, or telemonitoring if they con-
sisted of telephone contact for eliciting symptoms and
transmission of physiological data.
Our primary outcomes were all cause mortality, all
cause rate of admission to hospital (proportion of
patients readmitted to hospital at least once during fol-
low-up), and rate of admission to hospital as a result of
chronic heart failure (proportionof patients readmitted
to hospital at least once during follow-up).Our second-
ary outcomes were health related quality of life, cost,
and acceptability.
Validity assessment and data abstraction
Two investigators (RAC, SCI) independently
reviewed the results of the searches for study inclusion
and extracted data. We excluded any studies in which
additional home or clinic visits (more than usual care)
were offered to patients in the intervention or control
arms. Study quality (particularly method), randomisa-
tion, and intervention, were judged using accepted cri-
teria and compared with the review protocol.9
Disagreements between the two reviewers were
resolved by a third reviewer (SS, FAMcA, or JGFC).
Data abstraction was carried out independently and
blinded by RAC and SCI, with FAMcA checking
extracted data. Overall the inter-rater reliability on
key inclusion criteria (randomisation and intervention)
was strong (κ score 0.73, 95% confidence interval 0.54
to 0.92).27
Study characteristics and data synthesis
Owing to the expected differences in patient popula-
tions, programme characteristics, and length of follow-
up, we carried out our primary analyses using the Der-
Simonian and Laird random effects model. Analyses
were carried out using RevMan 4.2 (Nordic Cochrane
Centre).9 As the outcomes of interest were relatively
common we calculated risk ratios and 95% confidence
intervals. The risk difference (difference between
observed proportion of the event in the treatment
and usual care groups9) was calculated by subtracting
the risk of the event in the usual care group from that of
the treatment group. These data are presented with
95% confidence intervals.
We carried out intention to treat analyses—that is, all
patients and their outcomes were analysed in the
groups to which they were allocated, regardless of
whether they received the treatment. We examined
for statistical heterogeneity in each outcome of interest
using Cochran’s Q test and I2 statistic. Secondary out-
comes (expected to be reported less often) were
described and tabulated.
Potentially relevant articles identified
and screened for retrieval (n=499)
Randomised controlled trials of remote monitoring in chronic
  heart failure (n=14):
    Structured telephone support (n=9)
    Telemonitoring (n=4)
    Both (n=1)
Excluded (n=220):
  Systematic reviews (n=22)
  Non-randomised controlled trials (n=53)
  Home visits (n=31)
  Internet mail monitoring (n=11)
  Frequent visits to heart failure clinic (n=6) 
  Studies not reporting end points of interest (n=13)
  Additional manuscripts supplementary to main papers
    (n=84)
Studies retrieved for more detailed evaluation (n=234)
Fig 1 | Flow of study selection
RESEARCH
page 2 of 9 BMJ | ONLINE FIRST | bmj.com
RESULTS
Overall 234 of 499 citationswere reviewed in detail.Of
these, 14w1-w14 randomised controlled trials (4264
patients) were eligible for inclusion (fig 1). One trial
was three armedw1; to avoid double counting of the
control patients the results for the control arm were
shared between the two comparisons for the pooled
analysis of all remote monitoring programmes, but all
patients in the control armswere counted in each of the
sub-analyses (telephone support v usual care, telemo-
nitoring v usual care). Four trials evaluated
telemonitoring, w11-w14 nine evaluated structured tele-
phone support,w2-w10 and onew1 evaluated both. Ninety
five per cent of the included trials were captured by the
Medline search, 2% fromCINAHL, and3% fromhand
searching and contact with experts.
The length of follow-up of these trials ranged from
three to 16 months, the mean ages of participants ran-
ged from 57 to 75 years, and all trials enrolled patients
with symptoms (New York Heart Association classifi-
cation range II-IV, left ventricular ejection fraction
<40%). Structured telephone support programmes
included monitoring of symptoms, medicine
management, and education and counselling on life-
style. All the telemonitoring programmes included
transfer of daily data on weight, pulse, blood pressure,
and electrocardiographic findings.
The quality of the studies was evaluated using
Cochrane recommendations.9 The 14 included studies
were rated as adequate, reporting 61% of the recom-
mended quality variables. Six (42%) described con-
cealment and some level of blinding of patient or
outcome assessors, and seven (50%) reported comple-
teness of follow-up (table 1).
Quantitative data synthesis
All cause mortality
All 14 trials reported all cause mortality (15 compari-
sons, 581 deaths, fig 2) and the pooled estimates showed
a statistically significant 20% reduction (95% confidence
interval 8% to 31%) with remote monitoring pro-
grammes. Thebenefits were greaterwith telemonitoring
(risk ratio 0.62, 0.45 to 0.85, P=0.003, based on 127
deaths in 807 patients) than with structured telephone
support (0.85, 0.72 to 1.01, P=0.06, based on 482 deaths
in 3542 patients), although this difference did not
Table 2 |Effect of remotemonitoring on chronic heart failure related quality of life, cost, and acceptability to patients
Study End point (months)
Health related quality of
life* and depression Effect on cost or patient Cost of intervention Acceptability of intervention to patients
Cleland et al 2005 (TEN-
HMS study)w1
400 days† — — — 4.1% of patients refused to accept
technology in their homes, 2.9% of
patients asked for equipment to be
removed, and 1.8% discontinued
recording. Overall patient acceptance was
91.2%. 96%of patientswerewell satisfied
with the system and 97% found the
telemonitoring devices easy to use
Barth 2001w4 2 Increase inscoresonMLHFQ
(P≤0.0005)
— $23.60/patient —
Riegel et al 2002w5 6 — 46% reduction in inpatient
costs (P=0.04)
$443/patient Patient satisfaction was significantly
higher among people assigned to
intervention group compared with usual
care group (P=0.01)
Laramee et al 2003w6 3 — $2482/patient (average)
reduction
$228.52/patient
(average)
—
Tsuyuki et al 2004w8 6 — $C2531/patient reduction — —
GESICA investigators
2005w9 (DIAL trial)
16 (mean) Increase in scores on
MLHFQ, mean total score,
intervention v control 30.6 v
35.0, mean difference 4.4,
95% CI 1.8 to 6.9, P=0.001
— — —
Riegal et al 2006w10 6 MLHFQ (NS), EQ-5D (NS),
depression by PHQ-9 (NS)
No effect on cost of care for
heart failure or all cause acute
care cost
— —
De Lusignan et al 2001w11 12 GHQ, CCHFSQ (NS) — — Video link over standard telephone lines
was not found to be useful by participants
Goldberg et al 2003
(WHARF trial)w12
6 MLHFQ (P=0.22), SF-12
(physical score P=0.15,
mental score P=0.73), HDS
(P=0.57)
— — —
Woodend et al 2003w13 3 Increase inscoresonMLHFQ
(P=0.025)
— — Very highly satisfied
$1.00 (£0.51; €0.75). $C1.00 (£0.44; €0.65).
Blank cells indicate no data available for variables. NS=not significant or no P value reported; MLHFQ=Minnesota living with heart failure questionnaire; PHQ-9=patient health questionnaire
9 item; GHQ=general health questionnaire; CHFSQ=chronic heart failure symptomatology questionnaire; HDS=health distress score.
*Variance between baseline and study end point, details provided as included in study.
†Patient acceptability measured at 400 days.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 9
achieve significance (P=0.18) using the adjusted indirect
comparisonmethod described by Song et al.28Mortality
data from these 14 trials showed little heterogeneity
(P=0.56, I2=0%).
All cause admission to hospital
Of the eight trials (nine comparisons) that reported
rates of all cause admission to hospital (fig 3), none
reported a statistically significant result. Even the
pooled estimates did not show a significant benefit on
this end point with remote monitoring programmes
(0.95, 0.89 to 1.02).
Hospital admissions as a result of chronic heart failure
Nine trials (10 comparisons) reported rates of admis-
sion to hospital as a result of chronic heart failure, and
although only one reported a statistically significant
benefit, all trials showed similar relative reductions (P
for heterogeneity 0.76, I2=0%) and the pooled results
showed a reduction of 21% (11% to 31%) with remote
monitoring programmes (fig 4). Although no appreci-
able difference was found between the relative reduc-
tions seen with telemonitoring and telephone support
programmes, evidence from randomised trials was
insufficient to conclusively state that telemonitoring
programmes reduce admissions to hospital since only
one of these trials reported this outcome.
Quality of life, cost, adherence, and patient acceptability
Only six trials examined the effect of the intervention on
health relatedqualityof life (table 2).Of these trials, three
reported a significant and substantial improvement in
quality of life between the intervention and control
groups at the end of follow-up. The effect of the inter-
vention on healthcare costs was reported in only four of
these trials (all of structured telephone support); how-
ever, three of the four trials reported lower healthcare
costs for patients randomised to the intervention
(table 2). The cost of the intervention was infrequently
reported and variation existed between programmes
(table 2). None of the trials on telemonitoring reported
the cost of the intervention or its effect on healthcare
costs. Acceptability of the intervention to the patient
was under-reported, with only four trials reporting this
outcome (table 2). Three of these trials reported that the
intervention was acceptable to patients, with patients
from one trial of telemonitoring considering the video
link not useful.w11
An analysis of publication bias using funnel plots
showed anunlikely possibility of biaswithin studies show-
ing a reduction in mortality after remote monitoring.
DISCUSSION
This systematic review found that remote monitoring
programmes for patients with chronic heart failure
Structured telephone
Cleland et al 2005w1
Gattis et al 1999w2
Rainville 1999w3
Barth et al 2001w4
Riegel et al 2002w5
Laramee et al 2003w6
DeBusk et al 2004w7
Tsuyuki et al 2004w8
GESICA Investigators 2005w9
Riegel et al 2006w10
Subtotal (95% CI)
Test for heterogeneity: χ2=6.41, df=8, P=0.60, I 2=0%
Test for overall effect: z=1.88, P=0.06
Telemonitoring
Cleland et al 2005w1
De Lusignan et al 2001w11
Goldberg et al 2002w12
Woodend et al 2003w13
Capomolla et al 2004w14
Subtotal (95% CI)
Test for heterogeneity: χ2=2.22, df=4, P=0.70, I 2=0%
Test for overall effect: z=2.93, P=0.003
0.1 0.2 0.5 1 2 5 10
Study
35/173 
3/90 
1/17 
0/17 
16/130 
13/141 
21/228 
16/140 
116/760 
6/69 
1765 
36/168 
2/10 
11/138 
5/62 
5/67 
445
Treatment
group
28/85 
5/91 
4/17 
0/17 
32/228 
15/146 
29/234 
12/136 
122/758 
8/65 
1777 
28/85 
3/10 
26/142 
4/59 
7/66 
362
Control
group
No with event/No in group
12.06 
1.10 
0.50 
6.90 
4.35 
7.67 
4.29 
39.73 
2.15 
78.75 
12.31 
0.89 
4.90 
1.35 
1.80 
21.25 
100.00
Weight
(%)
0.61 (0.40 to 0.94)
0.61 (0.15 to 2.46)
0.25 (0.03 to 2.01)
Not estimable
0.88 (0.50 to 1.54)
0.90 (0.44 to 1.82)
0.74 (0.44 to 1.26)
1.30 (0.64 to 2.64)
0.95 (0.75 to 1.20)
0.71 (0.26 to 1.93)
0.85 (0.72 to 1.01)
0.65 (0.43 to 0.99)
0.67 (0.14 to 3.17)
0.44 (0.22 to 0.85)
1.19 (0.34 to 4.22)
0.70 (0.24 to 2.11)
0.62 (0.45 to 0.85)
0.80 (0.69 to 0.92)
Relative risk
(random) (95% CI)
Relative risk
(random) (95% CI)
-0.13 (-0.24 to -0.01)
-0.02 (-0.08 to 0.04)
-0.18 (-0.41 to 0.05)
0.00 (-0.11 to 0.11)
-0.02 (-0.09 to 0.05)
-0.01 (-0.08 to 0.06)
-0.03 (-0.09 to 0.02)
0.03 (-0.05 to 0.10)
-0.01 (-0.04 to 0.03)
-0.04 (-0.14 to 0.07)
-0.12 (-0.23 to 0.00)
-0.10 (-0.48 to 0.28)
-0.10 (-0.18 to -0.03)
0.01 (-0.08 to 0.11)
-0.03 (-0.13 to 0.07)
Risk difference
(random) (95% CI)
Favours
treatment
Favours
control
Fig 2 | Effect of remote monitoring on all cause mortality
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living in the community reduced admissions to hospi-
tal and all cause mortality by nearly one fifth while
improving health related quality of life, but had no sig-
nificant effect on all cause admission to hospital.
Although few studies have examined economic out-
comes, the three studies on structured telephone sup-
port suggested that the interventions were
economically cost effective Thus, this systematic
review builds on earlier ones56 of multidisciplinary
interventions for chronic heart failure by tackling key
issues and uncertainties relating to the specific effect of
telephone based programmes. This review is particu-
larly important as remote monitoring programmes
provide a potentially feasible option for dealing with
the expanding population of patients with chronic
heart failure that cannot be accommodated within
existing multidisciplinary chronic heart failure clinics
owing to constraints caused by geography or
resources.
The significant effect of structured telephone sup-
port on the risk of admissions to hospital for chronic
heart failure (risk differences ranged between 2% and
35%) can be attributed in part to the triage of patients
by telemonitoring nurse at the first sign of clinical dete-
rioration, and the consequent immediate intervention
of a primary care doctor.w5 w14 Similarly, all trials on
telemonitoring in this review involved daily transmis-
sion of vital signs, weight, and symptoms at various
time points to healthcare providers, thus potentially
leading to earlier detection andmanagement of clinical
deterioration by the patient ormanaging health profes-
sional.A recent study of rapid up-titration of βblockers
in 49 patients with chronic heart failure reported that
deterioration in symptoms, including weight gain,
oedema of the legs, and increasing dyspnoea, were
usually present eight to 12 days before admission to
hospital.29
The lack of effect of remotemonitoring programmes
on all cause admissions to hospital may require further
exploration. This observation is consistent with an ear-
lier meta-analysis.6 Importantly this result does not
simply reflect a paucity of data as there were more
events for this end point (1561 admissions in 3586
patients) than for deaths and admissions to hospital.
Reduced mortality will increase the duration of expo-
sure to the risk of admission and will reduce the effect
of intervention on this outcome. However, telemoni-
toring is likely to produce false alarms and pre-emptive
admissions in patients who are deteriorating but not
yet in crisis and also to lead to early discharge because
the patient still has a high level of monitoring at home.
Consequently, telemonitoring may be more effective
at shortening hospital stay than at reducing admissions.
Increased survival and admissions for common
comorbid conditions (for example, chronic respiratory
disease, fractures from falls, and cancer among partici-
pants who were typically elderly)30 may also prevent a
reduction in the frequency of admissions associated
with telemonitoring. Finally, remote monitoring in
patients with chronic heart failure focuses on indices
specific to that disease and treatment; it may have little
effect on other reasons for admission.Whether extend-
ing the range of monitoring to provide more compre-
hensive support will result in a further improvement in
health outcomes is yet to be determined.
Structured telephone
Cleland et al 2005w1
Riegel et al 2002w5
Laramee et al 2003w6
DeBusk et al 2004w7
Tsuyuki et al 2004w8
GESICA Investigators 2005w9
Riegel et al 2006w10
Subtotal (95% CI)
Test for heterogeneity: χ2=4.78, df=6, P=0.57, I 2=0%
Test for overall effect: z=1.44, P=0.15
Telemonitoring
Cleland et al 2005w1
Goldberg et al 2002w12
Subtotal (95% CI)
Test for heterogeneity: χ2=0.03, df=1, P=0.87, I 2=0%
Test for overall effect: z=0.21, P=0.83
0.1 0.2 0.5 1 2 5 10
Study
73/110 
56/130 
49/141 
116/228 
59/140 
261/760 
39/69 
1578 
75/106 
65/138 
244
Treatment
group
40/55 
114/228 
46/146 
117/234 
51/136 
296/758 
37/65 
1622 
40/55 
67/142 
197
Control
group
No with event/No in group
11.33 
8.89 
4.59 
15.21 
5.87 
28.29 
5.68 
79.85 
12.07 
8.08 
20.15 
100.00
Weight
(%)
0.91 (0.74 to 1.13)
0.86 (0.68 to 1.09)
1.10 (0.79 to 1.53)
1.02 (0.85 to 1.22)
1.12 (0.84 to 1.50)
0.88 (0.77 to 1.00)
0.99 (0.74 to 1.33)
0.94 (0.87 to 1.02)
0.97 (0.79 to 1.19)
1.00 (0.78 to 1.28)
0.98 (0.84 to 1.15)
0.95 (0.89 to 1.02)
Relative risk
(random) (95% CI)
Relative risk
(random) (95% CI)
-0.06 (-0.21 to 0.08)
-0.07 (-0.18 to 0.04)
0.03 (-0.08 to 0.14)
0.01 (-0.08 to 0.10)
0.05 (-0.07 to 0.16)
-0.05 (-0.10 to 0.00)
0.00 (-0.17 to 0.16)
-0.02 (-0.17 to 0.13)
0.00 (-0.12 to 0.12)
Risk difference
(random) (95% CI)
Favours
treatment
Favours
control
Fig 3 | Effect of remote monitoring on risk of all cause admission to hospital
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Quality of life, acceptability, and cost benefits were
infrequently reported in these trials. Although those
reporting these outcomes showed significant improve-
ments with remote monitoring, future studies of tele-
monitoring or structured telephone support
programmes should be encouraged to incorporate
such measures and outcomes in their reporting. The
same caveats and recommendations apply to cost
data arising from these studies.
Limitations of the study
A limitation of this review is the relatively small num-
ber of studies (n=14) and participants (n=4264). In
addition, few trials had follow-up beyond six months.
Thus our observations on the positive, short term ben-
efits of remote monitoring programmes may not
extend to longer term outcomes. However, the hazard
ratio for admission to hospital in patients with chronic
heart failure is not linear as the greatest risk of readmis-
sion in such patients occurs in three to six months.
Nevertheless, it is expected that the body of evidence
on remote monitoring for chronic heart failure will
expand considerably in the next decade as strategies
on communicating information become normalised
into medical practice and a better understanding is
gained of the content of care provided by remotemon-
itoring.
Furthermore, it is anticipated that the following stu-
dies will add to the evidence base in this specialty: the
as yet unpublished reports on the home or hospital in
heart failure31 trial, which showed an overall neutral
effect on mortality and admissions to hospital; the
recent work by the Scalvini et al team in Italy,32
which showed a significant reduction in risk of read-
mission (risk ratio 0.50, 95% confidence interval 0.34
to 0.73; P=0.01); and Riegel et al’sw10 most recent
paper, which questions the effect of this type of inter-
vention in non-Caucasian ethnic groups.
Conclusion
Although we have shown substantial and statistically
significant benefitswith remotemonitoring for patients
with chronic heart failure, monitoring is not a treat-
ment but rather a different way of systematically orga-
nising effective care. Thus programmes that include
remote monitoring should not be seen as a replace-
ment for specialist care8 or multidisciplinary chronic
heart failure clinics (two interventions that improve
outcomes633). However, remote monitoring may be
of particular benefit to patients who have difficulty
accessing specialised care because of geography, trans-
port, or infirmity.8 34
Structured telephone
Cleland et al 2005w1
Rainville 1999w3
Barth et al 2001w4
Riegel et al 2002w5
Laramee et al 2003w6
DeBusk et al 2004w7
Tsuyuki et al 2004w8
GESICA Investigators 2005w9
Riegel et al 2006w10
Subtotal (95% CI)
Test for heterogeneity: χ2=5.13, df=7, P=0.64, I 2=0%
Test for overall effect: z=3.63, P=0.0003
Telemonitoring
Cleland et al 2005w1
Subtotal (95% CI)
Test for heterogeneity: Not applicable
Test for overall effect: z=0.75, P=0.45
0.1 0.2 0.5 1 2 5 10
Study
32/110 
4/17 
0/17 
23/130 
18/141 
38/228 
37/140 
128/760 
21/69 
1612 
38/106 
106
Treatment
group
23/55 
10/17 
0/17 
63/228 
21/146 
43/234 
38/136 
169/758 
22/65 
1656 
23/55 
55
Control
group
No with event/No in group
8.87 
1.81 
8.90 
4.72 
10.29 
10.83 
37.94 
6.66 
90.02 
9.98 
9.98 
100.00
Weight
(%)
0.70 (0.45 to 1.07)
0.40 (0.16 to 1.03)
Not estimable
0.64 (0.42 to 0.98)
0.89 (0.49 to 1.59)
0.91 (0.61 to 135)
0.95 (0.64 to 1.39)
0.76 (0.61 to 0.93)
0.90 (0.55 to 1.47)
0.78 (0.68 to 0.89)
0.86 (0.57 to 1.28)
0.86 (0.57 to 1.28)
0.79 (0.69 to 0.89)
Relative risk
(random) (95% CI)
Relative risk
(random) (95% CI)
-0.13 (-0.28 to 0.03)
-0.35 (-0.66 to -0.04)
0.00 (-0.11 to 0.11)
-0.10 (-0.19 to -0.01)
-0.02 (-0.10 to 0.06)
-0.02 (-0.09 to 0.05)
-0.02 (-0.12 to 0.09)
-0.05 (-0.09 to -0.01)
-0.03 (-0.19 to 0.12)
-0.06 (-0.22 to 0.10)
Risk difference
(random) (95% CI)
Favours
treatment
Favours
control
Fig 4 | Effect of remote monitoring on risk of admission to hospital for chronic heart failure
WHAT IS ALREADY KNOWN ON THIS TOPIC
Systematic reviews on telephone support and
telemonitoring in patients with chronic heart failure have
provided inconclusive evidence of benefit
WHAT THIS STUDY ADDS
Remote monitoring has the potential to improve clinical
outcomes incommunitydwellingpatientswithchronic heart
failure
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Table 1 |Description of studies included in systematic review andmeta-analysis
Study Participants (location) Interventions and usual care
Reported
outcomes (study
end point)
Study quality
Randomisa-
tion Allocation concealment
Blinding
of
patients
and
assessors
Complete-
ness of
follow-up
Structured telephone (on
basis of symptom
reporting) and
telemonitoring (on basis
of symptom and sign
monitoring):
Cleland et al 2005
(TEN-HMS study)w1
426 patients (mean age
67 years) with a recent
admission for heart
failureand left ventricular
ejection fraction <40%
(Germany, Netherlands,
United Kingdom)
Patients assigned to nurse telephone support arm received a
telephone call each month by a heart failure specialist nurse to
assess symptoms and current drugs. Patients assigned to
telemonitoring received nurse telephone support and had their
weight, blood pressure, and electrocardiogram monitored twice
daily. Usual care consisted of a management plan forwarded to
patient’s primary care physician,whowasasked to implement it. If
the practice involved nurse titration of drugs this was allowed.
Patients were assessed at a research clinic every four months;
contact with clinic was discouraged between visits
Mortality,
readmission to
hospital,
compliance with
intervention
(15 months)
Random
permuted
blocks
After consent and
collection of baseline
data an independent
statistical centre was
contacted
NS 1% lost to
follow-up
Structured telephone
(on basis of symptom
reporting):
Gattis et al 1999
(PHARM study)w2
181 patients (mean age
67 years) with heart
failure being evaluated in
cardiology clinic (United
States)
Clinical pharmacist led drug review and patient education.
Regularly scheduled telephone contact (at 2, 12, and24weeks) to
detect clinical deterioration early. Control group received usual
care that did not include pharmacist providing recommendations
on drug therapy to attending physician or providing education to
patient. Patient assessment and education were provided by
attending physician, physician assistant, or nurse practitioner.
Patient was contacted by pharmacist by telephone to identify
clinical events
Mortality,
readmission to
hospital, drug
prescription (
6 months)
Computer
generated
Assignment revealed
after provision of consent
Yes ; NS NS
Rainville 1999w3 34 patients aged ≥
50 years (mean age
70 years) discharged
from hospital with heart
failure (United States)
Usual care plus pharmacist led drug review, patient education,
drug management before discharge and at days 3, 7, 30, and 90,
and 12 months. Usual care consisted of routine care and
preparation for discharge, including written prescriptions,
physician discharge instructions, and nurse review of diet,
treatment plans, and drugs. Nurses provided patient with
computer generated drug information sheets. Patients were
contacted by a pharmacist at 30 days, 90 days, and 12months to
determine readmissions
Mortality,
readmission to
hospital,
functional
assessment score
(12 months)
Method not
stated
Unclear Yes ; NS 2.9% lost to
follow-up
Barth et al 2001w4 34 patients (mean age
75 years) discharged
from acute care to home
with primary diagnosis of
chronic heart failure
(United States)
Structured nurse managed telephonic post-discharge programme
involving predischarge education plus post-discharge telephone
follow-up. Structured interaction at 72 hours, 144 hours, and then
fortnightly. Control group received routine discharge teaching at
time of discharge as per hospital procedure. Patients were
contacted at 2 months for collection of data
Mortality,
readmission to
hospital,
physician and
emergency
department visits,
quality of life, cost
of intervention
(3 months)
Method not
stated
Unclear NS NS
Riegel et al 2002w5 358 patients (mean aged
74 years) discharged
from hospital with heart
failure (United States)
Telephonic case management by registered nurse using decision
support software, involving patient educationandcounselling and
liaison with primary care physician. Patients were telephoned
within 5 days of discharge and thereafter at a frequency guided by
software and case manager (mean 17 calls). Usual care was not
standardised, and no formal telephonic case management was in
existence at these institutions. These patients presumably
received some education on heart failure management before
hospital discharge
Mortality,
readmission to
hospital,
physician and
emergency
department visits,
inpatient costs,
patient
satisfaction
(6 months)
Physicians
were unit of
randomisa-
tion, method
not stated
Unclear Physicians
blinded ;
NS
NS
Laramee et al 2003w6 287 patients (mean age
71 years) admitted to
hospital with primary or
secondary diagnosis of
chronic heart failure, left
ventricular systolic
dysfunction <40% or
radiological evidence of
pulmonary oedema
(United States)
Telephonic case management carried out by one nurse case
manager for chronic heart failure, involving four major
components: early discharge planning, patient and family
education on chronic heart failure, promotion of optimal drugs for
chronic heart failure and 12 weeks of telephone follow-up. Usual
care consisted of standard care typical of a tertiary care hospital. It
included inpatient social service evaluation (25%), dietary
consultation (15%), physiotherapy or occupational therapy
(17%), and education on drugs and chronic heart failure by
nurses. Post-discharge was carried out by the patient’s local
physician (44% received some home care services)
Mortality,
readmission to
hospital, inpatient
and outpatient
costs, drug
prescription and
adherence
(3 months)
Simple
randomisation
of first 42
patients,
followed by
randomisation
in blocks of
eight
Unclear NS 5.2% lost to
follow-up
DeBusk et al 2004w7 462 patients (mean age
72 years) admitted to
hospital with provisional
diagnosis of chronic
heart failure from Kaiser
Permanente (United
States)
Standardised telephonic physician directed nurse managed case
management, involving lifestyle education and drug management
for chronic heart failure. Patients contacted weekly for 6 weeks,
biweekly for 8weeks, and thenmonthly andbimonthly. Usual care
not clearly defined, but was provided by participating Kaiser
Permanente medical centres, seemed to involve a high frequency
of all of kinds of follow-up clinic visits (13 in 12 months after
admission to hospital)
Mortality,
readmission to
hospital,
emergency and
outpatient
department visits,
prescription of
recommended
pharmacotherapy
(12 months)
Sealed
assignment
using Efron
procedure
Research staff not
associated with
delivering intervention
provided sealed
assignment
NS ; Yes NS
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Tsuyuki et al 2004w8 276 patients (mean age
72 years) discharged
from hospital with heart
failure (Canada)
Early discharge planningwith provision of adherence aids, patient
education, regularly scheduled telephone contact with local
research coordinator at 2 and 4 weeks thenmonthly thereafter for
6 months. Recommendations to see primary care physician if not
receiving target doseof angiotensin converting enzyme inhibitor or
deterioration. Patients assigned tousual care received a pamphlet
on general heart disease before discharge, but no formal
counselling beyond what was routine at the hospital. Patients
were contacted monthly for 6 months to ascertain clinical events
Mortality,
readmission to
hospital, drug
adherence,
physician and
emergency
department visits,
cost analysis (
6 months)
Computer
generated
sequence
using block
randomisation
stratified by
study site
Randomised by a
telephone call to project
office
NS 2.5% lost to
follow-up
GESICA Investigators
2005 (DIAL trial)w9
1518 outpatients (mean
age 65 years) with stable
chronic heart failure
(Argentina)
Nurses trained in management of patients with chronic heart
failure carried out structured telephone follow-up involving
adherence to diet and treatment, monitoring of symptoms, control
of fluid retention, and daily physical activity. Patients were
contacted four times in the first fortnight and then as needed.
Patients in control group were followed by their attending
cardiologists and received care similar to the intervention group
Mortality,
readmission to
hospital,qualityof
life (mean
16 months)
Permuted
block
randomisation
using
concealed
randomisation
lists, stratified
according to
patient’s
cardiologist
After provision of
consent, patient’s
cardiologist contacted
study centre
NS ; Yes 0.5% lost to
follow-up
Riegel et al 2006w10 134 Hispanic patients
(mean age 72 years)
admitted to hospital with
chronic heart failure
(United States)
Education, monitoring, and guidance by bilingual-bicultural
Mexican-American registered nurses by telephone case
management standardised using decision support software.
Patientswere contacted onaveragewithin5 days of discharge and
thereafter at a frequency guided by the software and nurse case
manager over a 6 month period (mean 13.5 calls to patients and
8.4 additional calls to families). Printed educational material was
provided monthly and on request in relevant language. Usual care
was not standardised and no formal disease management
programme existed at these institutions. Standard of usual care
was that patients were educated about heart failure management
before discharge, assuming that nurse spoke patient’s language
or someone bilingual was available to translate. In reality, only a
small portion of staff were bilingual so much of the discharge
instruction was provided in writing. Typical discharge instructions
included a drug list and institution specific discharge instruction
sheet with handwritten notes to follow a low sodium diet and
contact the physician if symptoms occur
Mortality,
readmission to
hospital, cost of
care, self reported
health related
quality of life and
depression (
6 months)
Sealed
envelopes
attached to
sequential
data forms
Sealed envelopes
openedafter collectionof
baseline data
NS ; Yes No losses to
follow-up
Telemonitoring (on basis
of symptom and sign
monitoring):
De Lusignan et al
2001w11
20 patients (mean age
75 years) with heart
failure confirmed by
cardiologist, identified
from database of
academic general
practice (United
Kingdom)
Telemonitoring of vital signs (pulse, blood pressure, weight) and
clinical status assessed daily by nurses along with video
consultations with a nurse weekly for 3 months, fortnightly for
3 months, thenmonthly. Usual care consisted of standard general
practice treatment; in addition they had pulse, blood pressure,
and weight measured quarterly. They were evaluated in the same
manner as the intervention group
Mortality,
compliance with
intervention and
drugs, patient
satisfaction,
quality of life (
12 months)
Random table
allocation
Unclear NS NS
Goldberg et al 2002
(WHARF trial)w12
280 patients (mean age
59 years) admitted to
hospital with NYHA class
III-IV, with left ventricular
ejection fraction ≤35%
(United States)
Daily transmission of weight and symptoms using a customised
monitor; data were reviewed daily by nurses and concerns
reported to physician. Patients in control group were instructed to
contact their physician for weight increases of more than a
prespecified amount or if their symptoms of heart failure
worsened. They hadaweight log to bring to visits. Follow-up visits,
other than study visits, were at the discretion of the treating
physician. Telephone contacts were permitted at the discretion of
the treating physician or nurse
Mortality,
readmission to
hospital,
emergency
department visits,
quality of life,
patient
satisfaction,
compliance with
intervention
(mean 6 months)
Method not
stated
Unclear NS ; Yes 11% lost to
follow-up
Woodend et al
2003w13
121 patients (mean age
68 years) with
symptomatic heart
failure (NYHA class II or
greater) (Canada)
Daily transmission of weight and periodic transmission of
electrocardiogram and blood pressure. Weekly video conferences
by telehome care nurse. Video conferences more frequent in first
few weeks and tapered over 3 months. Usual care was not
described
Mortality,
readmission to
hospital,qualityof
life, emergency
department visits,
patient
satisfaction (
3 months)
Method not
stated
Unclear NS NS
Capomolla et al
2004w14
133 patients (mean age
57 years) discharged
from specialist chronic
heart failure unit to home
(Italy)
Daily communication of vital signs (including weight, systolic
blood pressure, heart rate) and symptoms with review by nurses
and physicians. Access to medical staff by phone as needed was
available. Usual care consisted of referral to patient’s primary care
physician or cardiology department at discharge. Post-discharge
care was governed by care provider
Mortality,
readmission to
hospital,
emergency
department visits,
compliance with
intervention (
12 months)
Method not
stated
Unclear NS NS
NYHA=New York Heart Association. NS=Not stated.
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